Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (36)

2020

  1. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak

    International Journal of Dermatology, Vol. 59, Núm. 12, pp. 1475-1484

2018

  1. Facial spiny follicular hyperkeratosis induced by vemurafenib

    Journal of Dermatology

2017

  1. A fatal drug interaction

    Medicina Clinica, Vol. 149, Núm. 9, pp. e47

  2. Genetic 3′UTR variation is associated with human pigmentation characteristics and sensitivity to sunlight

    Experimental Dermatology, Vol. 26, Núm. 10, pp. 896-903

  3. Patrones dermatoscópicos de tumores no melanocíticos

    Piel, Vol. 32, Núm. 5, pp. 298-304

  4. Subacute cutaneous lupus erythematosus induced by masitinib

    International Journal of Dermatology, Vol. 56, Núm. 11, pp. 1180-1181

2016

  1. Subacute cutaneous lupus erythematosus induced by mitotane

    JAMA Dermatology

  2. Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: A pilot clinical trial

    AIDS, Vol. 30, Núm. 1, pp. 75-82

2015

  1. Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: The ACTUO observational prospective multicenter cohort trial in 643 patients

    BMC Dermatology, Vol. 15, Núm. 1

  2. Diffuse reactive angioendotheliomatosis secondary to the administration of trabectedin and pegfilgrastim

    American Journal of Dermatopathology, Vol. 37, Núm. 7, pp. 581-584

  3. Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study

    PLoS ONE, Vol. 10, Núm. 4

  4. Herpes zoster: A potential risk associated with fingolimod treatment

    International Journal of Dermatology

  5. Severe folliculitis with secondary impetiginization in the scalp of a woman treated with panitumumab

    International Journal of Dermatology, Vol. 54, Núm. 6, pp. e226-e229

2014

  1. Facial Angiofibroma Severity Index (FASI): Reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibroma

    Clinical and Experimental Dermatology, Vol. 39, Núm. 8, pp. 888-893

  2. Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma

    PLoS ONE, Vol. 9, Núm. 4

  3. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk

    European Journal of Cancer, Vol. 50, Núm. 18, pp. 3168-3177

2013

  1. Acral erythema worsened by intravenous infusions of cyclosporin

    Dermatology Online Journal

  2. Cutaneous graft versus host disease in pediatric multivisceral transplantation

    Pediatric Dermatology, Vol. 30, Núm. 3, pp. 335-341

  3. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population

    BMC Cancer, Vol. 13

  4. rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility

    PLoS ONE, Vol. 8, Núm. 3